CRANE NXT CO (CXT) Fundamental Analysis & Valuation

NYSE:CXTUS2244411052

Current stock price

41.83 USD
+1.24 (+3.05%)
At close:
41.83 USD
0 (0%)
After Hours:

This CXT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CXT Profitability Analysis

1.1 Basic Checks

  • CXT had positive earnings in the past year.
  • CXT had a positive operating cash flow in the past year.
  • Each year in the past 5 years CXT has been profitable.
  • In the past 5 years CXT always reported a positive cash flow from operatings.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • CXT's Return On Assets of 4.66% is fine compared to the rest of the industry. CXT outperforms 70.16% of its industry peers.
  • With a decent Return On Equity value of 11.58%, CXT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 7.93%, CXT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CXT is above the industry average of 8.33%.
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROIC 7.93%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • With a decent Profit Margin value of 8.76%, CXT is doing good in the industry, outperforming 79.84% of the companies in the same industry.
  • CXT's Profit Margin has improved in the last couple of years.
  • The Operating Margin of CXT (15.91%) is better than 90.32% of its industry peers.
  • In the last couple of years the Operating Margin of CXT has grown nicely.
  • CXT has a Gross Margin of 42.48%. This is in the better half of the industry: CXT outperforms 72.58% of its industry peers.
  • CXT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. CXT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CXT is creating some value.
  • The number of shares outstanding for CXT has been increased compared to 1 year ago.
  • The number of shares outstanding for CXT has been reduced compared to 5 years ago.
  • The debt/assets ratio for CXT is higher compared to a year ago.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • CXT has an Altman-Z score of 1.86. This is not the best score and indicates that CXT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CXT has a Altman-Z score of 1.86. This is in the lower half of the industry: CXT underperforms 66.13% of its industry peers.
  • The Debt to FCF ratio of CXT is 5.75, which is a neutral value as it means it would take CXT, 5.75 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CXT (5.75) is comparable to the rest of the industry.
  • CXT has a Debt/Equity ratio of 0.91. This is a neutral value indicating CXT is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.91, CXT is doing worse than 86.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Altman-Z 1.86
ROIC/WACC0.84
WACC9.45%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.50 indicates that CXT should not have too much problems paying its short term obligations.
  • CXT has a worse Current ratio (1.50) than 76.61% of its industry peers.
  • CXT has a Quick Ratio of 1.20. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
  • CXT has a worse Quick ratio (1.20) than 69.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.2
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. CXT Growth Analysis

3.1 Past

  • The earnings per share for CXT have decreased by -4.92% in the last year.
  • The Earnings Per Share has been growing slightly by 1.12% on average over the past years.
  • Looking at the last year, CXT shows a quite strong growth in Revenue. The Revenue has grown by 11.43% in the last year.
  • CXT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.71% yearly.
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%

3.2 Future

  • CXT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.32% yearly.
  • Based on estimates for the next years, CXT will show a small growth in Revenue. The Revenue will grow by 5.29% on average per year.
EPS Next Y6.3%
EPS Next 2Y8.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.38%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

8

4. CXT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.30, which indicates a very decent valuation of CXT.
  • Based on the Price/Earnings ratio, CXT is valued cheaper than 92.74% of the companies in the same industry.
  • CXT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.51.
  • The Price/Forward Earnings ratio is 9.69, which indicates a very decent valuation of CXT.
  • 91.13% of the companies in the same industry are more expensive than CXT, based on the Price/Forward Earnings ratio.
  • CXT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.76.
Industry RankSector Rank
PE 10.3
Fwd PE 9.69
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • 89.52% of the companies in the same industry are more expensive than CXT, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CXT indicates a rather cheap valuation: CXT is cheaper than 89.52% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.12
EV/EBITDA 8.57
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)1.63
PEG (5Y)9.2
EPS Next 2Y8.32%
EPS Next 3YN/A

6

5. CXT Dividend Analysis

5.1 Amount

  • CXT has a Yearly Dividend Yield of 1.74%.
  • CXT's Dividend Yield is rather good when compared to the industry average which is at 0.46. CXT pays more dividend than 93.55% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, CXT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.74%

5.2 History

  • The dividend of CXT is nicely growing with an annual growth rate of 6.42%!
  • CXT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • CXT pays out 26.88% of its income as dividend. This is a sustainable payout ratio.
  • CXT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP26.88%
EPS Next 2Y8.32%
EPS Next 3YN/A
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CXT Fundamentals: All Metrics, Ratios and Statistics

CRANE NXT CO

NYSE:CXT (4/1/2026, 8:18:26 PM)

After market: 41.83 0 (0%)

41.83

+1.24 (+3.05%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners113.86%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner Change5.59%
Market Cap2.40B
Revenue(TTM)1.66B
Net Income(TTM)145.10M
Analysts81.82
Price Target91.36 (118.41%)
Short Float %12.25%
Short Ratio7.87
Dividend
Industry RankSector Rank
Dividend Yield 1.74%
Yearly Dividend0.68
Dividend Growth(5Y)6.42%
DP26.88%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.06%
Min EPS beat(2)0.03%
Max EPS beat(2)0.1%
EPS beat(4)4
Avg EPS beat(4)1.37%
Min EPS beat(4)0.03%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)0.66%
EPS beat(12)10
Avg EPS beat(12)5.62%
EPS beat(16)13
Avg EPS beat(16)5.54%
Revenue beat(2)2
Avg Revenue beat(2)3.34%
Min Revenue beat(2)1.89%
Max Revenue beat(2)4.78%
Revenue beat(4)3
Avg Revenue beat(4)1.73%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)4.78%
Revenue beat(8)4
Avg Revenue beat(8)0.72%
Revenue beat(12)7
Avg Revenue beat(12)1.19%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.37%
EPS NY rev (1m)-5.05%
EPS NY rev (3m)-5.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.26%
Revenue NY rev (1m)-0.57%
Revenue NY rev (3m)-0.34%
Valuation
Industry RankSector Rank
PE 10.3
Fwd PE 9.69
P/S 1.45
P/FCF 12.12
P/OCF 9.95
P/B 1.92
P/tB N/A
EV/EBITDA 8.57
EPS(TTM)4.06
EY9.71%
EPS(NY)4.32
Fwd EY10.32%
FCF(TTM)3.45
FCFY8.25%
OCF(TTM)4.2
OCFY10.05%
SpS28.84
BVpS21.81
TBVpS-8.15
PEG (NY)1.63
PEG (5Y)9.2
Graham Number44.64
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 11.58%
ROCE 10.34%
ROIC 7.93%
ROICexc 8.69%
ROICexgc 29.25%
OM 15.91%
PM (TTM) 8.76%
GM 42.48%
FCFM 11.97%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.13%
ROE(5y)16.85%
ROIC(3y)11.93%
ROIC(5y)11.12%
ROICexc(3y)13.26%
ROICexc(5y)12.51%
ROICexgc(3y)48.49%
ROICexgc(5y)45.78%
ROCE(3y)15.59%
ROCE(5y)14.95%
ROICexgc growth 3Y-18.71%
ROICexgc growth 5Y16.5%
ROICexc growth 3Y-13.43%
ROICexc growth 5Y8.62%
OM growth 3Y-6.41%
OM growth 5Y12.78%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 5.75
Debt/EBITDA 3.08
Cap/Depr 40.53%
Cap/Sales 2.61%
Interest Coverage 4.74
Cash Conversion 65.25%
Profit Quality 136.66%
Current Ratio 1.5
Quick Ratio 1.2
Altman-Z 1.86
F-Score4
WACC9.45%
ROIC/WACC0.84
Cap/Depr(3y)44.3%
Cap/Depr(5y)36.54%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.17%
Profit Quality(3y)119.51%
Profit Quality(5y)128.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
EPS Next Y6.3%
EPS Next 2Y8.32%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%
Revenue Next Year6.38%
Revenue Next 2Y5.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.09%
EBIT growth 3Y0.45%
EBIT growth 5Y1.82%
EBIT Next Year18.85%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y17.55%
FCF growth 3Y-11.36%
FCF growth 5Y-6.44%
OCF growth 1Y12.8%
OCF growth 3Y-7.59%
OCF growth 5Y-4.84%

CRANE NXT CO / CXT Fundamental Analysis FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 8 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


How profitable is CRANE NXT CO (CXT) stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


What is the financial health of CRANE NXT CO (CXT) stock?

The financial health rating of CRANE NXT CO (CXT) is 3 / 10.


What is the earnings growth outlook for CRANE NXT CO?

The Earnings per Share (EPS) of CRANE NXT CO (CXT) is expected to grow by 6.3% in the next year.